BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

Bio Digital Artificial Intelligence

Guardant Health and ConcertAI Partner to Advance Cancer Research with Multi-Modal Real-World Data

Collaboration enables insights from ConcertAI national database of 5.5M clinical records and Guardant profiling data across 60+ tumor types Longitudinal...

January 17, 2025 | News

Guardant Health and ConcertAI Partner to Advance Cancer Research with Multi-Modal Real-World Data

Collaboration enables insights from ConcertAI national database of 5.5M clinical records and Guardant profiling data across 60+ tumor types Longitudinal...

January 17, 2025 | News

Menarini Group Partners with Insilico Medicine on AI-Discovered Oncology Asset in $550M Licensing Deal

This is the second asset Menarini Group has inlicensed from Insilico Medicine which was discovered through their generative AI platform, si...

January 13, 2025 | News

NEC and Biomy Partner to Advance AI-Powered Digital Pathology for Precision Cancer Care

NEC Corporation (NEC; TSE: 6701) and Biomy, Inc. (Biomy) have signed a Memorandum of Understanding (MoU) to form a joint marketing partnership aimed at adv...

January 10, 2025 | News

Heather Hargett on How Merck’s HUB Organoids Acquisition is Reshaping 3D Cell Culture and Drug Development

In an exclusive interview with BioPharma APAC, Heather Hargett, Head of Cell Biology Reagents & Tools at MilliporeSigma ( Merck KGaA, Darmstadt, German...

January 10, 2025 | News

Leica Biosystems Partners with Indica Labs to Transform AI-Driven Digital Pathology

Combining leading hardware and software is expected to provide a compelling solution for digital pathology users across the full translational medicine par...

January 09, 2025 | News

Insilico Medicine Reports Positive Phase I Results for ISM5411, Advancing AI-Driven IBD Treatment

Insilico Medicine (“Insilico”), a clinical-stage generative artificial intelligence (AI)-driven drug discovery and development company, today s...

January 08, 2025 | News

BGM Group Enters AI-Driven Healthcare and Insurance Sector with Strategic Acquisition of AIX Inc.

BGM Group Ltd. (Nasdaq: BGM) (the "Company" or "BGM"), a leading global pharmaceutical enterprise, announced completion of the acquisition of the int...

December 30, 2024 | News

Axcelead Drug Discovery Partners Joins Forces with Astellas Pharma to Advance Targeted Protein Degrader Research

Axcelead Drug Discovery Partners, Inc. announced today that it has entered into a drug discovery service agreement with Astellas Pharma, Inc. (HQ: Ch...

December 26, 2024 | News

Shanghai Matwings Secures Series A Funding to Advance AI-Driven Protein Design with AccelProtein™

Shanghai Matwings Technology Co., Ltd. ('Matwings'), a global leader in AI-driven protein design, announced the successful completion of Series A funding r...

December 26, 2024 | News

South Korea invests in Generate Biomedicines through Samsung to drive global biopharma innovation.

Samsung Life Science Fund invests in Generate:Biomedicines, a Flagship Pioneering company leading in AI-enabled protein therapeutics disc...

December 18, 2024 | News

Driving Precision Medicine with AI: Tomasz Jetka, PhD, on Ardigen’s Vision for 2025

In an exclusive conversation with BioPharma APAC, Tomasz Jetka, PhD, Director of AI at Ardigen, delves into the company's ambitious plans to revolutionize ...

December 16, 2024 | Interview

25 Leading AI Companies to Watch in 2025: Transforming Drug Discovery and Precision Medicine

Biopharma in 2025: AI Transforming Drug Discovery and Precision Medicine The biopharma landscape in 2025 is poised for an unprecedented transformation, dr...

December 13, 2024 | Analysis

GE HealthCare Introduces Deep Learning Imaging Solutions to Enhance Diagnostics

More than 80 percent of all health system visits include an imaging exam,i making radiology an essential part of diagnostics and healthcare an...

December 06, 2024 | News

Stay Connected